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Inhibition of amplification of Chlamydia truchomatis 
plasmid DNA by the ligase chain reaction associated 
with female urines 
Max Chernesky, Sylvia Chong, DanJang, Kathy Luinstra, Michael Faught and 
James Mahony 
McMaster University Regional Virology and Chlamydiology Laboratory and The  Father Sean 
O'Sullivan Research Centre, St Joseph's Hospital, Hamilton, Ontario, Canada 
Objective: To determine the rate of inhibition of ligase chain reaction (LCR) amplification of Chlamydia trachomatis 
plasmid DNA in urines from pregnant and non-pregnant women, to correlate inhibitors with urinary substances through 
urinalysis, and to explore methods of removing inhibitors from urine. 
Methods: First-void urines (FVUs) from 287 non-pregnant and 101 pregnant women (15-40 years of age) in Hamilton, 
Canada were tested for urinary factors by urinalysis and for C. trachomatis by LCR. A sample of each urine was 'spiked' 
with a positive control containing approximately one infectious unit of C. trachomatis Lz serovar. 
Results: Complete inhibition of DNA amplification was observed in nine of 287 (3.1%) urines from non-pregnant 
women and in one of 101 (1%) who were pregnant. Partial inhibition (> 20% reduction in signal) was observed in an 
additional five of 388 (1.3%) urines. Nine urines contained C. trachomatis plasmid DNA, but none of these contained 
inhibitors of LCR. By multivariate analysis, the only substances in urine which were significantly and independently 
related to LCR inhibition were nitrites. Holding the urines a t  4°C or -70°C overnight reduced the numbers which were 
inhibitory by approximately 50%. Diluting the urines 1:lO or extracting with phenol/chloroform removed all inhibition 
and retained amplifiable DNA. 
Conclusions: We conclude that urinary inhibitors of C. trachomatis DNA amplification by LCR are minimal and appear 
to be related to the presence of nitrites. We anticipate that most would disappear in transit or during processing and 
that a positive control for every urine is not warranted, considering the added cost and work associated with duplicate 
testing. 
Key words: Female urine, inhibitors, ligase chain reaction, nitrites, removal 
INTRODUCTION 
The observation that Chlamydia trackomatis DNA 
amplification by ligase chain reaction (LCR) in first- 
void urine (FVU) from women detected as many 
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positive patients as testing endocervical swabs by cell 
culture or antigen testing [ 1-41, indicated the potential 
of this new technology for screening asymptomatic 
women. The rationale for performing LCR on non- 
invasive FVU was that it could lead to identification 
and treatment of lower genital tract infections, pre- 
venting upper tract dsease with its sequelae of chronic 
pelvic pain, ectopic pregnancy and infertility. 
Few, if any, of the studies reported false-positive 
findings with LCR after discrepant analysis of the extra 
positives, indicating that the technology was not only 
very sensitive but would not require confirmatory 
testing, because of high specificity. 
None of the reports showed the technology to be 
100% sensitive, leading to speculation that this may be 
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due to a loss of reactivity during transportation to the 
laboratory or the presence of inhibitors of LCR in the 
clinical specimens (1.e. cervical swabs, urines). In a 
side-by-side comparison of LCK and P C R  performed 
on 767 female specimens [5], we observed 15 (2.9%) 
urines which were positive in one test or the other, 
which might be explained by the presence ofinhibitory 
substances. We designed a protocol which involved 
‘spiking’ a sample of urine with C. truchomutis and 
demonstrated inhibition in some urines when tested by 
LCR, PCR or both assays. 
These observations led us to perform a study with 
the following objectives: (1) to determine the pre- 
valence of inhibitors of LCR for C. traclzornutis plasmid 
DNA in FVUs collected from pregnant and non- 
pregnant patients; (2) to perform urinalysis and, by 
cohorting patients with and without inhibitors, analyze 
associations with urinary factors; and (3) to examine 
strategies to remove inhibitors of LCR. 
METHODS 
Samples of 25-50 niL of FVU from 388 women (101 
pregnant) were processed the same day they were 
received in the laboratory after being held overnight at  
4°C. Aliquots of urine were tested in the LCR test 
(LCX Abbott Diagnostics, Chicago, USA) with and 
without a C. traciionratis ‘spike’ (approximately 1 
infectious unit (IFU) Lr C. truchornatis propagated in 
McCoy cells and diluted in sterile water) [5]. After 
centrifuging and resuspension of 1 mL of FVU in the 
kit  buffer, the specimen was divided into two volumes 
of 0.5 mL. One volume received 40 pL of the spike and 
the other received only buffer. Both samples were then 
processed through the LCR kit protocol. Those 
specimens demonstrating 20-100%1 inhibition of the 
‘spike’ were recorded. Urines showing complete 
inhibition were extracted with phenol/chloroform [6] 
and retested for inhibitors at dilutions of 1:1, 1:4 and 
1:IO. Aliquots of the same inhibitory samples after 
storage overnight at  4°C and -70°C were tested the 
next day for inhibitors at  the dilutions specified above. 
Fresh urines were tested for the presence of 
leukocytes, nitrites, protein, blood, ketone and glucose, 
and specific gravity and pH were measured with the 
Multistix 8 SG dipstick (Bayer Corp., Germany). The 
dipstick was read according to the manufacturer’s 
instructions by the automated urine chemistry analyzer, 
Clinitex 200+ (Bayer Corp.). Positive urinary protein 
results from the dipstick were confirmed by a 
seniiquantitative sulfosalicylic acid (SSA) test, which 
simply involved mixing 1 .0 mL of centrifuged urine 
with 3.0 mL of 3% SSA. After 5 niin, the degree of 
turbidity caused by the precipitation of denatured 
protein was observed and graded from negative to 4+.  
For microscopic examination of the urine, 10-1 5 niL 
aliquots were spun at 1000 rev/min for 5 niin. A drop 
of the resulting sediment was transferred to a micro- 
scope slide. Examination for epithelial cells, red and 
white blood cells, mucus, yeast, bacteria, casts and 
various types of crystals (oxalate, phosphate, urate) was 
done under both low and high magnification of the 
light microscope by trained technicians [7] .  Kesults 
were reported as an average of the fields observed. 
RESULTS 
Spiking the fresh urines resulted in partial or complete 
inhibition in the C. rruclzornutis LCR assay in 3.9% 
(151288) of the samples (Table 1).  The inhibition rate 
was not remarkably different between urines from 
pregnant (3.0%) and non-pregnant (4.1 96) women. 
There was a higher rate of complete inhibition in 
urines from non-pregnant women (3.1 %) than in 
urines from pregnant women (1.0%). 
The 10  urines with complete inhibition were 
compared to the other 378 for the presence of glucose, 
Table 1 Female urines showing complete or partial 
inhibition” of C. truckomatis plasrnid amplification by LCK 
after spiking with laboratory-grown L2 strain 
Number of iirines showing ~iihibitioii 
Female popiilation Coinulete (%)) Partial W) Ariv I%) 
Non-pregnant (r1=287) Y (3.1) 3 (1.0) 12 (4.1) 
All women ( r i = 3 X X )  10 (2.6) 5 (1.3) 15 (3.9) 
Pregnant (n=101)  1 (1 .O) 2 (2.o) 3 (3.0) 
“A minimum of 20%) reduction in the assay sigiial m e m t  pdrtial 
inhibition; conipletc inhibition nirant reduction of the signal 
bclo\% the cut-off of powivity. 
Table 2 Feniale urines demonstrating complete inhibition 
of LCK after treatment 
Trea tnients 
Sub~equent Nniiiber of urine$ (‘XI) 
Initial dilutionc with complete inhibition 
4°C overnight 1:l 4/Y (44.4) 
1:4 2/<9 (22.2) 
1 : l O  0/9 (0.0) 
-70°C overnight 1.1 
1:4 
1 : l O  
5/Y (55.6) 
O/Y (00) 
O/Y (0 0) 
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hemoglobin, protein, ketones, leukocytes, nitrites, p- 
human chorionic gonadotrophin (HCG), crystals 
(urates, oxalates, phosphates), bacteria, yeast and casts. 
Multivariate analysis of the variables showed only 
the presence of nitrites to be independently and 
significantly associated with the presence of inhibitors 
(odds ratio (OR)=14.36; p=O.O11). 
Results of experiments designed to remove in- 
hibitors are summarized in Table 2. Nine of the 10 
urines which demonstrated complete inhibition of 
LCR had sufficient volume for them to be processed 
through the inhibition removal protocols. Storage at 
4°C or -70°C overnight rendered about half of the 
urines non-inhibitory. Dilution of the urines 1:4 
removed inhibition from seven of the nine specimens. 
Phenol/chloroform extraction or 1: 10 dilution rendered 
all nine urines non-inhibitory. A subset of nine urines 
was replica-treated on three occasions for removal of 
inhibitors, to assess reproducibility of the procedures; 
there were no variations in the results of the three 
procedures. 
Nine urines were positive in the C. trachomatis 
LCR test (all from non-pregnant patients) when tested 
without a spike, but none of these showed any 
inhibition. Examination of the reactivity of the 
inhibitory urines after spiking and removal of inhibitors 
did not suggest any of these urines to be masked by the 
presence of inhibitors. 
DISCUSSION 
The percentages of urines inhibitory for LCR in our 
study were 2.6% (complete) and 3.9% (any reduction 
in signal between 20% and 100%). These rates are 
slightly higher than our previous observation of 1.9% 
[5]. The only other published study reporting in- 
hibition in the LCR test examined urine from 1136 
pregnant women [ 8 ] .  These urines were stored at 4°C 
for less than 3 days and then sent unrefrigerated for up 
to 24 h to a testing laboratory. They were subsequently 
held for a few days at - 80 "C before testing in the LCR 
assay. Performing a double gold standard comparison, 
they found 15 urine samples negative by the plasmid 
LCR test but positive by other tests in a cervical or 
urine sample. Seven of the urine samples tested positive 
in an LCR test using primers for the major outer- 
membrane protein (MOMP). These investigators did 
not perform inhibitor studies. However, if all 15 urines 
did contain inhibitors for plasmid LCR, the rate would 
be low, at 1.3% (15/1136), which is similar to the rate 
in our pregnant patients. In a letter published by 
Rabenau et a1 [9], the authors assumed the presence of 
inhibitors in urines from female prostitutes based on a 
comparison of LCR on urines with enzyme immuno- 
assay (EIA) on cervical swabs. There were eight samples 
in the study negative by PCR and positive by EIA in 
the cervical swab, which may have been inhibitory. 
This would be a rate of 3% (8/265), which is sirmlar 
to the rate in our female population. These workers 
were also performing comparisons of P C R  and tran- 
scription-mediated amplification (TMA). 
Other amplification assays for C. trachomatis nucleic 
acids, such as PCR, have been reported to be sensitive 
to inhibitors [6,10-121. Some inhibitors of P C R  were 
removed by dilution, freezing and thawing, heating, or 
prolonged storage of the sample prior to amplification. 
Our sample treatment studies on completely inhibited 
urine demonstrated that storage at 4°C or -70°C 
removed approximately 50% of the inhibition. All of 
the inhibition of LCR could be removed by 1:lO 
dilution after storage at  4 "C or - 70 "C or by extraction 
with phenol/chloroform. We questioned whether 
treatments to remove inhibitors (storage, dilution or 
extraction) would render a Chlamydia-positive sample 
negative. A subset of inhibitory urines was 'spiked' 
before treatment to remove inhibitors, and all samples 
maintained a positive LCR signal after treatment (data 
not shown). 
This is the first report of an attempt to relate 
inhibition of LCR for C. trachomatis plasmid DNA to 
substances found in urine. O f  14 analytes determined 
by urinalysis, nitrites were the only substances signi- 
ficantly and independently related to the presence of 
LCR inhibitors. 
In summary, we have demonstrated a low rate of 
inhibition for LCR amplification of C. trachomatis 
plasmid DNA (ranging from 1% to 4%). There were no 
rate differences between pregnant and non-pregnant 
women. Although inhibitors were present, none of 
the inhibitory urines were from infected patients and 
the nine patients with C. trachomatis DNA showed no 
inhibitors. Most, if not all, inhibition was removed 
by storage, dilution or phenol/chloroform extraction, 
suggesting that most inhibitors in clinical samples such 
as urine might disappear in transit or during processing 
and that a positive control for every sample might not 
be cost-efficient. 
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